Summary information and primary citation

PDB-id
9hxv; DSSR-derived features in text and JSON formats; DNAproDB
Class
oxidoreductase
Method
X-ray (1.9 Å)
Summary
Crystal structure of tet2-DNA in complex with iox1
Reference
Willems S, Maksumic L, Niggenaber J, Lin TC, Schulz T, Weisner J, Sievers S, Muller MP, Summerer D, Rauh D (2025): "Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation." Acs Med.Chem.Lett., 16, 804-810. doi: 10.1021/acsmedchemlett.5c00042.
Abstract
Ten-eleven translocation (TET) methylcytosine dioxygenases are part of the epigenetic regulatory machinery that erases DNA methylation. Aberrant TET activities are frequently found in hematopoietic malignancies, where loss of TET2 function leads to DNA hypermethylation. A comprehensive understanding of the biological role of TETs is essential to elucidate disease pathogenesis and identify novel therapeutic strategies. We present a robust pipeline integrating protein X-ray crystallography, molecular modeling, and pharmacophore analysis to advance the current TET inhibitor development. In addition, we have synthesized and evaluated a series of 8-hydroxyquinoline (8-HQ) derivatives, demonstrating their potential as chemical tools to explore TET function further. These findings lay the groundwork for a TET-centered therapeutic approach.

Cartoon-block schematics in six views (download the tarball)

PyMOL session file

Download PDB file

View in 3Dmol.js

List of 2 5mC-amino acid contacts

No. 1 B.5CM6: stacking-with-A.ARG1261 stacking-with-A.ASP1384 stacking-with-A.TYR1902 not-WC-paired not-in-duplex

No. 2 C.5CM6: stacking-with-A.TYR1294 is-WC-paired is-in-duplex [-]:.GT/Ac.